CoChat

Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis

Open access
Vahidinasab, Maliheh, Lilge, Lars, Reinfurt, Aline, Pfannstiel, Jens, Henkel, Marius, Morabbi Heravi, Kambiz, Hausmann, Rudolf · 2020 · Microbial Cell Factories

Published version of a preprint

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Background: Plipastatin is a potent Bacillus antimicrobial lipopeptide with the prospect to replace conventional antifungal chemicals for controlling plant pathogens. However, the application of this lipopeptide has so far been investigated in a few cases, principally because of the yield in low concentration and unknown regulation of biosynthesis pathways. B. subtilis synthesizes plipastatin by a non-ribosomal peptide synthetase encoded by the ppsABCDE operon. In this study, B. subtilis 3NA (a non-sporulation strain) was engineered to gain more insights about plipastatin mono-production. Results: The 4-phosphopantetheinyl transferase Sfp posttranslationally converts non-ribosomal peptide synthetases from inactive apoforms into their active holoforms. In case of 3NA strain, sfp gene is inactive. Accordingly, the first step was an integration of a repaired sfp version in 3NA to construct strain BMV9. Subsequently, plipastatin production was doubled after integration of a fully expressed degQ version from B. subtilis DSM10 T strain (strain BMV10), ensuring stimulation of DegU-P regulatory pathway that positively controls the ppsABSDE operon. Moreover, markerless substitution of the comparably weak native plipastatin promoter (P pps ) against the strong constitutive promoter P veg led to approximately fivefold enhancement of plipastatin production in BMV11 compared to BMV9. Intriguingly, combination of both repaired degQ expression and promoter exchange (P pps ::P veg ) did not increase the plipastatin yield. Afterwards, deletion of surfactin ( srfAA-AD ) operon by the retaining the regulatory comS which is located within srfAB and is involved in natural competence development, resulted in the loss of plipastatin production in BMV9 and significantly decreased the plipastatin production of BMV11. We also observed that supplementation of ornithine as a precursor for plipastatin formation caused higher production of plipastatin in mono-producer strains, albeit with a modified pattern of plipastatin composition. Conclusions: This study provides evidence that degQ stimulates the native plipastatin production. Moreover, a full plipastatin production requires surfactin synthetase or some of its components. Furthermore, as another conclusion of this study, results point towards ornithine provision being an indispensable constituent for a plipastatin mono-producer B. subtilis strain. Therefore, targeting the ornithine metabolic flux might be a promising strategy to further investigate and enhance plipastatin production by B. subtilis plipastatin mono-producer strains.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12934-020-01468-0

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Comparison of cultivation parameters for a B. subtilis JABs24 (168 sfp +) and b B. subtilis BMV9 (3NA sfp +); The shake flask cultivations were performed in mineral salt medium containing 20 g/L glucose and 50 mM urea as carbon and nitrogen sources at 30 °C and 120 rpm. Besides optical density (OD600), glucose consumption, plipastatin and surfactin production were detected
Fig. 1 Comparison of cultivation parameters for a B. subtilis JABs24 (168 sfp +) and b B. subtilis BMV9 (3NA sfp +); The shake flask cultivations were performed in mineral salt medium containing 20 g/L glucose and 50 mM urea as carbon and nitrogen sources at 30 °C and 120 rpm. Besides optical density (OD600), glucose consumption, plipastatin and surfactin production were detectedCC BY · PubMed Central
Fig. 2 Overview about production of plipastatin (a) and surfactin (b) in respect to reached optical densities (OD600) of different engineered mutant strains after 48 h cultivation in mineral salt medium; BMV9, control strain (3NA sfp +); BMV10, repaired degQ expression; BMV11, promoter exchange of pps operon; BMV12, deletion of srfA operon; BMV13, combination of promoter exchange and srfA operon deletion; BMV14, combination of promoter exchange and repaired degQ expression
Fig. 2 Overview about production of plipastatin (a) and surfactin (b) in respect to reached optical densities (OD600) of different engineered mutant strains after 48 h cultivation in mineral salt medium; BMV9, control strain (3NA sfp +); BMV10, repaired degQ expression; BMV11, promoter exchange of pps operon; BMV12, deletion of srfA operon; BMV13, combination of promoter exchange and srfA operon deletion; BMV14, combination of promoter exchange and repaired degQ expressionCC BY · PubMed Central
Fig. 3 A Detected HPTLC chromatograms of the standard plipastatin in comparison with plipastatin produced by BMV9 (3NA sfp +) and BMV12 (3NA plipastatin mono-producer) with and without ornithine supplementation. Plipastatin standard produced by B. subtilis (Lipofabrik, France) [a], plipastatin produced by BMV9 strain after 48 h cultivation in mineral salt medium without any amino acid and with ornithine supplementation [b]; plipastatin produced by BMV12 strain after 48 h cultivation in mineral salt medium without amino acid and with ornithine supplementation [c]. B Comparison of plipastatin variants ratios in plipastatin standard and mono-producer BMV12 strain during exponential and stationary phase. The BMV12 was cultivated in mineral salt medium supplemented with 30 mM of ornithine. The samples were taken after 24 h (exponential phase) and 48 h (stationary phase). Peak areas were determined by extracted ion chromatograms for each plipastatin variant using their precise m/z values. Ratios of the peak areas of plipastatin variants were calculated within the standard and the two sample points
Fig. 3 A Detected HPTLC chromatograms of the standard plipastatin in comparison with plipastatin produced by BMV9 (3NA sfp +) and BMV12 (3NA plipastatin mono-producer) with and without ornithine supplementation. Plipastatin standard produced by B. subtilis (Lipofabrik, France) [a], plipastatin produced by BMV9 strain after 48 h cultivation in mineral salt medium without any amino acid and with ornithine supplementation [b]; plipastatin produced by BMV12 strain after 48 h cultivation in mineral salt medium without amino acid and with ornithine supplementation [c]. B Comparison of plipastatin variants ratios in plipastatin standard and mono-producer BMV12 strain during exponential and stationary phase. The BMV12 was cultivated in mineral salt medium supplemented with 30 mM of ornithine. The samples were taken after 24 h (exponential phase) and 48 h (stationary phase). Peak areas were determined by extracted ion chromatograms for each plipastatin variant using their precise m/z values. Ratios of the peak areas of plipastatin variants were calculated within the standard and the two sample pointsCC BY · PubMed Central
Fig. 4 Schematic illustration of the construction of PCR fragment in order to delete surfactin operon and retain back comS with the native PsrfA promoter using LFH-PCR method
Fig. 4 Schematic illustration of the construction of PCR fragment in order to delete surfactin operon and retain back comS with the native PsrfA promoter using LFH-PCR methodCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 71

Metadata

Authors
Vahidinasab, M., Lilge, L., Reinfurt, A., Pfannstiel, J., Henkel, M., Morabbi Heravi, K., & Hausmann, R.
Affiliations
University of Hohenheim (DE)
Corresponding author
Lilge, Lars
Venue
Microbial Cell Factories
Published
2020-11-10
Volume
19
Issue
1
Pages
205-205
ISSN
1475-2859 (ISSN-L)
OpenAlex
W3102096247
Cited by
68
References
67
Citations by year
2026: 6 · 2025: 15 · 2024: 22 · 2023: 8 · 2022: 10 · 2021: 7
FWCI
3.75
Type
journal article
Language
en
Open access
Licence
Locations
  • Microbial Cell Factories (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Food Security Center at the University of Hohenheim (57160040)
  • Projekt DEAL
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
plipastatin, Bacillus subtilis, nonribosomal peptide synthetase, DegQ, surfactin, COMS, biosynthetic regulation, antifungal lipopeptides, plant disease control
MeSH terms
Anti-Infective Agents, Bacillus subtilis, Bacterial Proteins, Fatty Acids, Oligopeptides, Operon, Peptide Synthases, Peptides, Cyclic, Promoter Regions, Genetic, Lipopeptides, Metabolic Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis. https://app.cochat.ai/papers/10.1186/s12934-020-01468-0
The paper
Vahidinasab, M., Lilge, L., Reinfurt, A., Pfannstiel, J., Henkel, M., Morabbi Heravi, K., & Hausmann, R. (2020). Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis. Microbial Cell Factories. https://doi.org/10.1186/s12934-020-01468-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.